Pediatrix Medical Group (NYSE:MD) Stock Price Expected to Rise, UBS Group Analyst Says

Pediatrix Medical Group (NYSE:MD) had its price target upped by investment analysts at UBS Group from $16.50 to $18.50 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s target price would indicate a potential upside of 18.83% from the stock’s current price.

A number of other research firms also recently weighed in on MD. Jefferies Financial Group boosted their target price on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Deutsche Bank Aktiengesellschaft boosted their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Truist Financial boosted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Friday. Finally, Macquarie began coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective for the company. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Trading Down 9.6 %

Shares of MD opened at $15.57 on Friday. The stock has a fifty day moving average price of $13.89 and a two-hundred day moving average price of $12.99. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. Pediatrix Medical Group has a 52-week low of $6.62 and a 52-week high of $17.67. The company has a market cap of $1.34 billion, a price-to-earnings ratio of -12.97, a PEG ratio of 1.74 and a beta of 1.57.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Analysts predict that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Institutional investors have recently made changes to their positions in the stock. Nomura Asset Management Co. Ltd. grew its stake in Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock valued at $33,000 after acquiring an additional 1,220 shares during the period. Quest Partners LLC grew its stake in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares during the period. Parkside Financial Bank & Trust grew its stake in Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after acquiring an additional 1,040 shares during the period. Quarry LP grew its stake in Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,662 shares during the period. Finally, AlphaQuest LLC grew its stake in Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after acquiring an additional 2,012 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.